Dermal Fillers

RESTYLANE® Lidocaine is a transparent gel with 20mg/ml hyaluronic acid for the purpose of facial tissue augmentation for the correction of wrinkles and for lip enhancement. Restylane® is a medical device. Restylane® has risks and benefits. Do not use in patients with bleeding disorders, or in patients taking anticoagulants or thombolytics. Do not inject intravascularly, where there is active disease, inflammation, infection or tumours near the intended treatment site. Possible side effects are injection site effects like swelling, bruising, and tenderness and inflammation. Product and treatment costs will apply. Further product details can be found in the full product information. Healthcare Logistics, Auckland. Restylane®, Medical Device Class III, to smooth facial wrinkles and enhance lips by restoring volume and fullness. Restylane® has risk and benefits. For product information check with your doctor or from product details with the supplier. Click for further details. Galderma, Auckland.

JUVEDERM ULTRA® & JUVEDERM ULTRA PLUS® injectable gels are Prescription Medicines containing 24mg/ml cross linked hyaluronic acid. They are used for filling of medium size and deep facial wrinkles by injection into the skin and for creating definition and volume in the lips. They should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Cautions: Use in an area that has been treated with another dermal filler. People with autoimmune disease; or who are pregnant, breastfeeding, age under 18; or have an increased susceptibility to keloid formation and hypertrophic scarring. Possible side effects: Injection site inflammatory reactions (redness/swelling/itching/pain on pressure); induration or nodules; discoloration; weak filling effect. If you have any side effects or concerns speak to your doctor. Note: Juvederm® treatment last from about 12-24 months. Allergan New Zealand Ltd. PO Box 1873 Auckland 1140, New Zealand.

BELOTERO® Intense Lidocaine is an injectable resorbable implant indicated to fill deep wrinkles and folds, as well as to restore and enhance soft tissue (e.g. contours of the face, lip volume etc. ). It is also suitable for correction of facial atrophic scars. The presence of lidocaine aims to reduce local pain associated with the injection of the gel and to improve patient comfort. Belotero® should not be used in pregnant and breastfeeding women, in young patients under 18 years old and in patients presenting a general infection. Precautions are active autoimmune disease, a history of severe multiple allergies or anaphylactic shock, a history of streptococcal disease, in patients pre-disposed to hypertrophic scars or cheloids, patients taking aspirin or non- steroidal anti-inflammatory medicines. A history of epilepsy, impaired cardiac conditions severe liver dysfunction or kidney dysfunction. Possible Adverse Effects, reactions usually associated with injections such as redness, erythema, oedema or pain sometimes accompanied by itching. Haematomas, swelling, discoloration in the treated area, allergy to one of the ingredients. Speak to your doctor if you have any of the above precautions or if adverse effects persist. New Zealand Medical and Scientific LTD, 2a Fisher Crescent, Mt. Wellington, Auckland.

TEOSYAL RHA® 1, TEOSYAL RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ®, TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP TEOSYAL KISS®, RHA KISS®, TEOSYAL® MESO, TEOSYAL® GLOBAL ACTION, TEOSYAL® DEEP LINES, , TEOSYAL® ULTIMATE and TEOSYAL® ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride They are class III medical devices. Caution for people on blood thinning medicines. Local side effects: inflammatory reactions (redness, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, disorders of pigmentation in skin and hair, abscesses, indurations, nodules (possibly granulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant. Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness, skin necrosis and stroke. Lasts 9 -12 months. Please consult your doctor pharmacist for more information. Please refer to instructions for use, local distributor. Healthcare Logistics, Auckland.

Dermal Fillers are a gel containing hyaluronic acid that is injected by a healthcare professional into or below the skin to smooth facial wrinkles and enhance lips by restoring volume and fullness. Do not have Dermal Filler injections in an area where there is a non resorbable implant or if you have irritated or infected skin, allergy to hyaluronic acid or other severe allergies, autoimmune disorders or hypersensitivity to local anesthetic or porphyria. Caution if you have a bleeding disorder, if you take medicines that prolong bleeding time, have had poor results with previous similar injections, have angina combined with rheumatism or a tendency to large scar formation. Dermal Filler treatments may result in some redness, swelling, pain or tenderness, itching and/or bruising which may last a few days. Inflammatory reactions can last up to two weeks in rare cases. See your healthcare professional if any side effects concern you. Exposure to excessive sunlight or extreme cold should be avoided until redness or swelling has resolved. Dermal Fillers are not recommended for people taking blood thinning medicines and they have not been tested in pregnant or breast feeding women. ALWAYS FOLLOW THE INSTRUCTIONS YOU ARE GIVEN.